Mohs' micrographic surgery for basal cell carcinoma

Clinical and Experimental Dermatology

Volumn 24, Issue 2, 1999, Pages 130-133

  Lawrence, C M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER GROWTH; CHEMOSURGERY; ESTHETIC SURGERY; EVIDENCE BASED MEDICINE; EXCISION; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; SURGICAL TECHNIQUE; TUMOR RECURRENCE; WOUND CLOSURE;

CARCINOMA, BASAL CELL; HUMANS; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0032900247     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00433.x     Document Type: Review

References (57)

1. 1 Mohs FE. Chemosurgery. A microscopically controlled method of cancer excision. Arch Surg 1941; 44: 279-95.
2. 2 Swanson NA. Mohs Surgery. Technique, indications, applications and the future. Arch Dermatol 1983; 119: 761-71.
3. 3 Cottell WI, Proper S. Mohs' Surgery, Fresh tissue technique. J Dermatol Surg Oncol 1982; 8: 576-87.
4. 4 Rappini RP. On the definition of Mohs surgery and how it determines appropriate surgical margins. Arch Dermatol 1992; 128: 673-8.
5. 5 Mohs FE. Chemosurgury. Microscopically controlled surgery for skin cancer. Springfield, IL: Charles C. Thomas, 1978: 153, Table 35.
6. 6 du Plessis PJ. Dahl MGCD, Malcolm AJ et al. Mohs surgery of periocular basal cell carcinoma using formalin-fixed sections and delayed closure. Br J Dermatol 1998; 138: 1003-8.
7. 7 Tromovitch AT, Stegman SJ. Microscopically controlled excision of cutaneous tumours. Chemosurgery, fresh tissue Technique. Canrer 1978; 41: 653-8.
8. 8 Swanson NA, Tromovitch TA, Stegeman SJ et al. A novel way of re-excising incompletely excised basal cell carcinomas. J Dermatol Surg Oncol 1980; 6: 438-9.
9. 9 Dzubow LM. Chemosurgical report: recurrence (persistence) of tumour following excision by Mohs surgery. J Dermatol Surg Oncol 1987; 13: 27-30.
10. 10 Wagner Jr RF, Cotlel WI. Mulli-focal recurrent basal cell carcinoma following primary tumour treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987; 17: 1047-9.
11. 11 Madsen A. Studies on basal cell epithelioma of the skin. Acta Pathologica Microbiologica Scand 1965; 177 (Suppl.): 9-63.
12. 12 Lang PG Jr, McKelvey AC, Nicholson JH. Three dimensional reconstruction of the superficial multicentric basal cell carcinoma using serial sections and a computer. Am J Dermatopathol 1987; 9: 198-203.
13. 13 Curson C, Weedon D. Spontaneous regression in basal cell carcinomas. J Cutan Pathol 1979; 6: 432-7.
14. 14 Duhin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 1983; 119: 373-7.
15. 15 Spiller WF. Spillcr RF. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984; 11: 8O8-14.
16. 16 Knox JM, Freeman RG, Duncan WC, Heaton CL. Treatment of skin cancer. Smith Med J 1967; 60: 241-6.
17. 17 Menn H, Robins P, Kopf AW, Bart RS. The recurrent basal cell epithelioma. Arch Dermatol 1971; 103: 628-31.
18. 18 Reymann F. Treatment of basal cell carcinoma with curettage. Arch Dermatol 1973; 108: 528-31.
19. 19 Simpson JR. The management of rodent ulcers by curettage and cauterization. Br J Dermatol 1966; 78: 147-8.
20. 20 Tromovitch TA. Skin cancer treatment by curettage and dessication. Calif Med 1965; 103: 107-8.
21. 21 Kopf AW, Bart RS. Schrager D et al. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-43.
22. 22 Williamson GS. Jackson R, Treatment of basal cell carcinoma by electrodessiccation and curettage. Can Med Ass J 1962; 86: 855-62.
23. 23 Sweet RD. The treatment of basal cell carcinoma by curettage. Br J Dermatol 1963; 75: 137-48.
24. 24 Mens BL, Bartlow GA, Haghigi P et al. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma. J Am Acad Dermatol 1983; 9: 383-8.
25. 25 Salasche SJ. Curettage and electrodesiccation in the treatment of midfacial basal cell carcinomas. J Am Acad Dermatol 1983; 8: .496-503.
26. 26 Doxanas MT. Green WR, Hiff CE. Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol 1981 ; 91: 726-36.
27. 27 Taylor GA, Barisoni D. Ten years of experience in the treatment of basal cell carcinoma. A study of factors associated with recurrence. Br J Surg 1973; 60: 522-5.
28. 28 Hayes H. Basal cell carcinoma: the East Grinstead experience. Plast Reconstr Surg 1962; 30: 273-80.
29. 29 Richmond JD, Davie RM. The significance of incomplete excision in patients with basal cell carcinoma., Br J Plast Surg 1987; 40: 63-7.
30. 30 Dellon AL, DeSilva S. Connolly M, Ross A. Prediction of recurrence in incompletely excised basal cell carcinoma. Plast Reconstr Surg 1985; 75: 850-71.
31. 31 Gooding CA, White G, Yatsuhashi M. Significance of marginal extension in excised basal cell carcinoma. New Engl J Med 1965; 273: 923-4.
32. 32 Pascal RR, Hobby LW, Lattes R, Crikelair GF. Prognosis of incompletely excised' versus completely excised' basal cell carcinoma. Plast Reconstr Surg 1968; 41: 328-32.
33. 33 McGregor JC. A study of basal cell carcinoma of the inner canthus 1967-72. Br J Surg 1979; 66: 522-3.
34. 34 Emmett AJJ. Broadbent GG, Basal cell carcinoma in Queensland. Aust N Z J Surg 1981: 51: 576-90.
35. 35 Lawrence CM, Dahl MGC, Comaish JS. Excision of skin malignancies without wound closure. Br J Dermatol 1986; 115: 563-71.
36. 36 Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123: 340-4.
37. 37 Salasche SJ. Amonette RA. Morphoeiform basal cell carcinoma. A study of sub-clinical extensions in a series of 51 cases. J Denmatol Surg Oncol 1981; 7: 387-94.
38. 38 Burg G. Hirsch RD, Konz B. Braun-Falco O. Histographic surgery: accuracy of visual assessment of the margins of basal cell epithelioma, J Dermatol Surg Oncol 1975; 1: 21-4.
39. 39 Hudson-Peacock M, Matthews JN. Lawrence CM. Relationship between excision, wound and specimen size in dermatological surgery. J Am Acad Dermatol 1995; 32: 1010-5.
40. 40 Koplin L, Zarem HA. Recurrent basal cell carcinoma. A review concerning the incidence, behaviour and management of recurrent basal cell carcinoma with emphasis on the incompletely excised lesion, Plast Reconstr Surg 1980; 65: 656-64.
41. 41 Emmelt AJ. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust N Z J Surg 1990; 60: 855-63.
42. 42 Robins P. Chemosurgery: my 15 years experience, J Dermatol Surg Oncol 1981; 7: 779-89.
43. 43 Rank B. Surgery and skin cancer. Am Roy Col Surg Engl 1973; 52: 148-64.
44. 44 Blomqvist G, Eriksson E, Lauritzen C. Surgical results in 477 basal cell carcinomas. Scand J Plast Reconstr Surg 1982; 16: 283-5.
45. 45 McCallum DI, Kinmont PDC. Basal cell carcinoma. An analysis of cases seen at a combined clinic. Br J Dermatol 1966; 78: 141-6.
46. 46 de Cholnoky TD. Cancer of the face. Ann Surg 1945; 122: 88-101.
47. 47 Monballiu G. Basal cell carcinomata of the head and neck. Br J Plast Surg 1968; 21: 200-11.
48. 48 Sundell B, Gylling U. Soivio AI. Treatment of basal cell carcinoma by plastic surgery. Acta Chir Scand 1966; 131: 249-53.
49. 49 Ward GE, Hendrick JW. Malignant epithelial tumours of the skin of head and neck. Am J Surg 1950; 79: 771-86.
50. 50 Smith SP, Grunde DJ. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 1991; 17: 26-30.
51. 51 Roenigk RK, Ratz JL, Bailin PL. Wheeland RG. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 1986; 12: 860-5.
52. 52 Sakura CY, Calamel PM. Comparison of treatment modalities for recurrent basal cell carcinoma. Plast Reconstr Surg 1979; 63: 492-6.
53. 53 Rank BK, Wakefield AR. Surgery of basal cell carcinoma. Br J Surg 1958; 45: 531-47.
54. 54 Cobbett JR. Recurrence of rodent ulcers after radiotherapy. Br J Surg 1965; 52: 347-9.
55. 55 Collin JRO. Basal cell carcinoma in the eyelid region, Br J Ophthal 1976; 60: 806-9.
56. 56 Bumsted RM, Ceilley RI, Panje WR, Crumley RL. Auricular malignant neoplasms. When is chemotherapy (Mohs' technique) necessary? Arch Otolaryngol 1981; 107: 721-4.
57. 57 Downes RN, Walker NPJ, Collin JRO. Micrographic (Mohs) surgery in the management of periocular basal cell epitheliomas. Eye 1990: 4: 160-8.